Global Broluzumab Biosimilars Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Broluzumab Biosimilars Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Broluzumab Biosimilars by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Broluzumab Biosimilars by Country/Region, 2017, 2022 & 2028

2.2 Broluzumab Biosimilars Segment by Type

2.2.1 Beovu

2.2.2 Vsiqq

2.2.3 Others

2.3 Broluzumab Biosimilars Sales by Type

2.3.1 Global Broluzumab Biosimilars Sales Market Share by Type (2017-2022)

2.3.2 Global Broluzumab Biosimilars Revenue and Market Share by Type (2017-2022)

2.3.3 Global Broluzumab Biosimilars Sale Price by Type (2017-2022)

2.4 Broluzumab Biosimilars Segment by Application

2.4.1 ARMD

2.4.2 Kaposi Sarcoma

2.4.3 Glioblastoma

2.5 Broluzumab Biosimilars Sales by Application

2.5.1 Global Broluzumab Biosimilars Sale Market Share by Application (2017-2022)

2.5.2 Global Broluzumab Biosimilars Revenue and Market Share by Application (2017-2022)

2.5.3 Global Broluzumab Biosimilars Sale Price by Application (2017-2022)

3 Global Broluzumab Biosimilars by Company

3.1 Global Broluzumab Biosimilars Breakdown Data by Company

3.1.1 Global Broluzumab Biosimilars Annual Sales by Company (2020-2022)

3.1.2 Global Broluzumab Biosimilars Sales Market Share by Company (2020-2022)

3.2 Global Broluzumab Biosimilars Annual Revenue by Company (2020-2022)

3.2.1 Global Broluzumab Biosimilars Revenue by Company (2020-2022)

3.2.2 Global Broluzumab Biosimilars Revenue Market Share by Company (2020-2022)

3.3 Global Broluzumab Biosimilars Sale Price by Company

3.4 Key Manufacturers Broluzumab Biosimilars Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Broluzumab Biosimilars Product Location Distribution

3.4.2 Players Broluzumab Biosimilars Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Broluzumab Biosimilars by Geographic Region

4.1 World Historic Broluzumab Biosimilars Market Size by Geographic Region (2017-2022)

4.1.1 Global Broluzumab Biosimilars Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Broluzumab Biosimilars Annual Revenue by Geographic Region

4.2 World Historic Broluzumab Biosimilars Market Size by Country/Region (2017-2022)

4.2.1 Global Broluzumab Biosimilars Annual Sales by Country/Region (2017-2022)

4.2.2 Global Broluzumab Biosimilars Annual Revenue by Country/Region

4.3 Americas Broluzumab Biosimilars Sales Growth

4.4 APAC Broluzumab Biosimilars Sales Growth

4.5 Europe Broluzumab Biosimilars Sales Growth

4.6 Middle East & Africa Broluzumab Biosimilars Sales Growth

5 Americas

5.1 Americas Broluzumab Biosimilars Sales by Country

5.1.1 Americas Broluzumab Biosimilars Sales by Country (2017-2022)

5.1.2 Americas Broluzumab Biosimilars Revenue by Country (2017-2022)

5.2 Americas Broluzumab Biosimilars Sales by Type

5.3 Americas Broluzumab Biosimilars Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Broluzumab Biosimilars Sales by Region

6.1.1 APAC Broluzumab Biosimilars Sales by Region (2017-2022)

6.1.2 APAC Broluzumab Biosimilars Revenue by Region (2017-2022)

6.2 APAC Broluzumab Biosimilars Sales by Type

6.3 APAC Broluzumab Biosimilars Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Broluzumab Biosimilars by Country

7.1.1 Europe Broluzumab Biosimilars Sales by Country (2017-2022)

7.1.2 Europe Broluzumab Biosimilars Revenue by Country (2017-2022)

7.2 Europe Broluzumab Biosimilars Sales by Type

7.3 Europe Broluzumab Biosimilars Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Broluzumab Biosimilars by Country

8.1.1 Middle East & Africa Broluzumab Biosimilars Sales by Country (2017-2022)

8.1.2 Middle East & Africa Broluzumab Biosimilars Revenue by Country (2017-2022)

8.2 Middle East & Africa Broluzumab Biosimilars Sales by Type

8.3 Middle East & Africa Broluzumab Biosimilars Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Broluzumab Biosimilars

10.3 Manufacturing Process Analysis of Broluzumab Biosimilars

10.4 Industry Chain Structure of Broluzumab Biosimilars

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Broluzumab Biosimilars Distributors

11.3 Broluzumab Biosimilars Customer

12 World Forecast Review for Broluzumab Biosimilars by Geographic Region

12.1 Global Broluzumab Biosimilars Market Size Forecast by Region

12.1.1 Global Broluzumab Biosimilars Forecast by Region (2023-2028)

12.1.2 Global Broluzumab Biosimilars Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Broluzumab Biosimilars Forecast by Type

12.7 Global Broluzumab Biosimilars Forecast by Application

13 Key Players Analysis

13.1 Novartis

13.1.1 Novartis Company Information

13.1.2 Novartis Broluzumab Biosimilars Product Offered

13.1.3 Novartis Broluzumab Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Novartis Main Business Overview

13.1.5 Novartis Latest Developments

13.2 Genentech

13.2.1 Genentech Company Information

13.2.2 Genentech Broluzumab Biosimilars Product Offered

13.2.3 Genentech Broluzumab Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Genentech Main Business Overview

13.2.5 Genentech Latest Developments

13.3 Roche

13.3.1 Roche Company Information

13.3.2 Roche Broluzumab Biosimilars Product Offered

13.3.3 Roche Broluzumab Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Roche Main Business Overview

13.3.5 Roche Latest Developments

13.4 Pfizer

13.4.1 Pfizer Company Information

13.4.2 Pfizer Broluzumab Biosimilars Product Offered

13.4.3 Pfizer Broluzumab Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Pfizer Main Business Overview

13.4.5 Pfizer Latest Developments

13.5 Sartorius

13.5.1 Sartorius Company Information

13.5.2 Sartorius Broluzumab Biosimilars Product Offered

13.5.3 Sartorius Broluzumab Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Sartorius Main Business Overview

13.5.5 Sartorius Latest Developments

13.6 Eli Lilly

13.6.1 Eli Lilly Company Information

13.6.2 Eli Lilly Broluzumab Biosimilars Product Offered

13.6.3 Eli Lilly Broluzumab Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Eli Lilly Main Business Overview

13.6.5 Eli Lilly Latest Developments

13.7 Bayer

13.7.1 Bayer Company Information

13.7.2 Bayer Broluzumab Biosimilars Product Offered

13.7.3 Bayer Broluzumab Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Bayer Main Business Overview

13.7.5 Bayer Latest Developments

13.8 Amgen

13.8.1 Amgen Company Information

13.8.2 Amgen Broluzumab Biosimilars Product Offered

13.8.3 Amgen Broluzumab Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Amgen Main Business Overview

13.8.5 Amgen Latest Developments

13.9 PlantForm

13.9.1 PlantForm Company Information

13.9.2 PlantForm Broluzumab Biosimilars Product Offered

13.9.3 PlantForm Broluzumab Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 PlantForm Main Business Overview

13.9.5 PlantForm Latest Developments

13.10 PharmaPraxis

13.10.1 PharmaPraxis Company Information

13.10.2 PharmaPraxis Broluzumab Biosimilars Product Offered

13.10.3 PharmaPraxis Broluzumab Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 PharmaPraxis Main Business Overview

13.10.5 PharmaPraxis Latest Developments

13.11 Samsung Bioepis

13.11.1 Samsung Bioepis Company Information

13.11.2 Samsung Bioepis Broluzumab Biosimilars Product Offered

13.11.3 Samsung Bioepis Broluzumab Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Samsung Bioepis Main Business Overview

13.11.5 Samsung Bioepis Latest Developments

13.12 Centus

13.12.1 Centus Company Information

13.12.2 Centus Broluzumab Biosimilars Product Offered

13.12.3 Centus Broluzumab Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Centus Main Business Overview

13.12.5 Centus Latest Developments

13.13 Cadila Pharmaceuticals

13.13.1 Cadila Pharmaceuticals Company Information

13.13.2 Cadila Pharmaceuticals Broluzumab Biosimilars Product Offered

13.13.3 Cadila Pharmaceuticals Broluzumab Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Cadila Pharmaceuticals Main Business Overview

13.13.5 Cadila Pharmaceuticals Latest Developments

13.14 Dr Reddy's

13.14.1 Dr Reddy's Company Information

13.14.2 Dr Reddy's Broluzumab Biosimilars Product Offered

13.14.3 Dr Reddy's Broluzumab Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Dr Reddy's Main Business Overview

13.14.5 Dr Reddy's Latest Developments

13.15 Aurobindo Pharma

13.15.1 Aurobindo Pharma Company Information

13.15.2 Aurobindo Pharma Broluzumab Biosimilars Product Offered

13.15.3 Aurobindo Pharma Broluzumab Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Aurobindo Pharma Main Business Overview

13.15.5 Aurobindo Pharma Latest Developments

13.16 Biocad

13.16.1 Biocad Company Information

13.16.2 Biocad Broluzumab Biosimilars Product Offered

13.16.3 Biocad Broluzumab Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Biocad Main Business Overview

13.16.5 Biocad Latest Developments

13.17 MAbxience

13.17.1 MAbxience Company Information

13.17.2 MAbxience Broluzumab Biosimilars Product Offered

13.17.3 MAbxience Broluzumab Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 MAbxience Main Business Overview

13.17.5 MAbxience Latest Developments

13.18 Hetero

13.18.1 Hetero Company Information

13.18.2 Hetero Broluzumab Biosimilars Product Offered

13.18.3 Hetero Broluzumab Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Hetero Main Business Overview

13.18.5 Hetero Latest Developments

13.19 Biocon

13.19.1 Biocon Company Information

13.19.2 Biocon Broluzumab Biosimilars Product Offered

13.19.3 Biocon Broluzumab Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 Biocon Main Business Overview

13.19.5 Biocon Latest Developments

13.20 Kirin Biologics

13.20.1 Kirin Biologics Company Information

13.20.2 Kirin Biologics Broluzumab Biosimilars Product Offered

13.20.3 Kirin Biologics Broluzumab Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.20.4 Kirin Biologics Main Business Overview

13.20.5 Kirin Biologics Latest Developments

13.21 Mylan

13.21.1 Mylan Company Information

13.21.2 Mylan Broluzumab Biosimilars Product Offered

13.21.3 Mylan Broluzumab Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.21.4 Mylan Main Business Overview

13.21.5 Mylan Latest Developments

13.22 BeiGene

13.22.1 BeiGene Company Information

13.22.2 BeiGene Broluzumab Biosimilars Product Offered

13.22.3 BeiGene Broluzumab Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.22.4 BeiGene Main Business Overview

13.22.5 BeiGene Latest Developments

13.23 Innovent

13.23.1 Innovent Company Information

13.23.2 Innovent Broluzumab Biosimilars Product Offered

13.23.3 Innovent Broluzumab Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.23.4 Innovent Main Business Overview

13.23.5 Innovent Latest Developments

13.24 Qilu Pharmaceutical

13.24.1 Qilu Pharmaceutical Company Information

13.24.2 Qilu Pharmaceutical Broluzumab Biosimilars Product Offered

13.24.3 Qilu Pharmaceutical Broluzumab Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.24.4 Qilu Pharmaceutical Main Business Overview

13.24.5 Qilu Pharmaceutical Latest Developments

13.25 Hengrui Pharmaceuticals

13.25.1 Hengrui Pharmaceuticals Company Information

13.25.2 Hengrui Pharmaceuticals Broluzumab Biosimilars Product Offered

13.25.3 Hengrui Pharmaceuticals Broluzumab Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.25.4 Hengrui Pharmaceuticals Main Business Overview

13.25.5 Hengrui Pharmaceuticals Latest Developments

13.26 Hisun Pharmaceutical

13.26.1 Hisun Pharmaceutical Company Information

13.26.2 Hisun Pharmaceutical Broluzumab Biosimilars Product Offered

13.26.3 Hisun Pharmaceutical Broluzumab Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.26.4 Hisun Pharmaceutical Main Business Overview

13.26.5 Hisun Pharmaceutical Latest Developments

13.27 TOT BIOPHARM

13.27.1 TOT BIOPHARM Company Information

13.27.2 TOT BIOPHARM Broluzumab Biosimilars Product Offered

13.27.3 TOT BIOPHARM Broluzumab Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.27.4 TOT BIOPHARM Main Business Overview

13.27.5 TOT BIOPHARM Latest Developments

13.28 Luye Pharmaceutical

13.28.1 Luye Pharmaceutical Company Information

13.28.2 Luye Pharmaceutical Broluzumab Biosimilars Product Offered

13.28.3 Luye Pharmaceutical Broluzumab Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.28.4 Luye Pharmaceutical Main Business Overview

13.28.5 Luye Pharmaceutical Latest Developments

13.29 Henlius

13.29.1 Henlius Company Information

13.29.2 Henlius Broluzumab Biosimilars Product Offered

13.29.3 Henlius Broluzumab Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.29.4 Henlius Main Business Overview

13.29.5 Henlius Latest Developments

14 Research Findings and Conclusion

Table 1. Broluzumab Biosimilars Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Broluzumab Biosimilars Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Beovu

Table 4. Major Players of Vsiqq

Table 5. Major Players of Others

Table 6. Global Broluzumab Biosimilars Sales by Type (2017-2022) & (K Units)

Table 7. Global Broluzumab Biosimilars Sales Market Share by Type (2017-2022)

Table 8. Global Broluzumab Biosimilars Revenue by Type (2017-2022) & ($ million)

Table 9. Global Broluzumab Biosimilars Revenue Market Share by Type (2017-2022)

Table 10. Global Broluzumab Biosimilars Sale Price by Type (2017-2022) & (K USD/Unit)

Table 11. Global Broluzumab Biosimilars Sales by Application (2017-2022) & (K Units)

Table 12. Global Broluzumab Biosimilars Sales Market Share by Application (2017-2022)

Table 13. Global Broluzumab Biosimilars Revenue by Application (2017-2022)

Table 14. Global Broluzumab Biosimilars Revenue Market Share by Application (2017-2022)

Table 15. Global Broluzumab Biosimilars Sale Price by Application (2017-2022) & (K USD/Unit)

Table 16. Global Broluzumab Biosimilars Sales by Company (2020-2022) & (K Units)

Table 17. Global Broluzumab Biosimilars Sales Market Share by Company (2020-2022)

Table 18. Global Broluzumab Biosimilars Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Broluzumab Biosimilars Revenue Market Share by Company (2020-2022)

Table 20. Global Broluzumab Biosimilars Sale Price by Company (2020-2022) & (K USD/Unit)

Table 21. Key Manufacturers Broluzumab Biosimilars Producing Area Distribution and Sales Area

Table 22. Players Broluzumab Biosimilars Products Offered

Table 23. Broluzumab Biosimilars Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Broluzumab Biosimilars Sales by Geographic Region (2017-2022) & (K Units)

Table 27. Global Broluzumab Biosimilars Sales Market Share Geographic Region (2017-2022)

Table 28. Global Broluzumab Biosimilars Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Broluzumab Biosimilars Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Broluzumab Biosimilars Sales by Country/Region (2017-2022) & (K Units)

Table 31. Global Broluzumab Biosimilars Sales Market Share by Country/Region (2017-2022)

Table 32. Global Broluzumab Biosimilars Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Broluzumab Biosimilars Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Broluzumab Biosimilars Sales by Country (2017-2022) & (K Units)

Table 35. Americas Broluzumab Biosimilars Sales Market Share by Country (2017-2022)

Table 36. Americas Broluzumab Biosimilars Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Broluzumab Biosimilars Revenue Market Share by Country (2017-2022)

Table 38. Americas Broluzumab Biosimilars Sales by Type (2017-2022) & (K Units)

Table 39. Americas Broluzumab Biosimilars Sales Market Share by Type (2017-2022)

Table 40. Americas Broluzumab Biosimilars Sales by Application (2017-2022) & (K Units)

Table 41. Americas Broluzumab Biosimilars Sales Market Share by Application (2017-2022)

Table 42. APAC Broluzumab Biosimilars Sales by Region (2017-2022) & (K Units)

Table 43. APAC Broluzumab Biosimilars Sales Market Share by Region (2017-2022)

Table 44. APAC Broluzumab Biosimilars Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Broluzumab Biosimilars Revenue Market Share by Region (2017-2022)

Table 46. APAC Broluzumab Biosimilars Sales by Type (2017-2022) & (K Units)

Table 47. APAC Broluzumab Biosimilars Sales Market Share by Type (2017-2022)

Table 48. APAC Broluzumab Biosimilars Sales by Application (2017-2022) & (K Units)

Table 49. APAC Broluzumab Biosimilars Sales Market Share by Application (2017-2022)

Table 50. Europe Broluzumab Biosimilars Sales by Country (2017-2022) & (K Units)

Table 51. Europe Broluzumab Biosimilars Sales Market Share by Country (2017-2022)

Table 52. Europe Broluzumab Biosimilars Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Broluzumab Biosimilars Revenue Market Share by Country (2017-2022)

Table 54. Europe Broluzumab Biosimilars Sales by Type (2017-2022) & (K Units)

Table 55. Europe Broluzumab Biosimilars Sales Market Share by Type (2017-2022)

Table 56. Europe Broluzumab Biosimilars Sales by Application (2017-2022) & (K Units)

Table 57. Europe Broluzumab Biosimilars Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Broluzumab Biosimilars Sales by Country (2017-2022) & (K Units)

Table 59. Middle East & Africa Broluzumab Biosimilars Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Broluzumab Biosimilars Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Broluzumab Biosimilars Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Broluzumab Biosimilars Sales by Type (2017-2022) & (K Units)

Table 63. Middle East & Africa Broluzumab Biosimilars Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Broluzumab Biosimilars Sales by Application (2017-2022) & (K Units)

Table 65. Middle East & Africa Broluzumab Biosimilars Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Broluzumab Biosimilars

Table 67. Key Market Challenges & Risks of Broluzumab Biosimilars

Table 68. Key Industry Trends of Broluzumab Biosimilars

Table 69. Broluzumab Biosimilars Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Broluzumab Biosimilars Distributors List

Table 72. Broluzumab Biosimilars Customer List

Table 73. Global Broluzumab Biosimilars Sales Forecast by Region (2023-2028) & (K Units)

Table 74. Global Broluzumab Biosimilars Sales Market Forecast by Region

Table 75. Global Broluzumab Biosimilars Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Broluzumab Biosimilars Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Broluzumab Biosimilars Sales Forecast by Country (2023-2028) & (K Units)

Table 78. Americas Broluzumab Biosimilars Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Broluzumab Biosimilars Sales Forecast by Region (2023-2028) & (K Units)

Table 80. APAC Broluzumab Biosimilars Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Broluzumab Biosimilars Sales Forecast by Country (2023-2028) & (K Units)

Table 82. Europe Broluzumab Biosimilars Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Broluzumab Biosimilars Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Middle East & Africa Broluzumab Biosimilars Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Broluzumab Biosimilars Sales Forecast by Type (2023-2028) & (K Units)

Table 86. Global Broluzumab Biosimilars Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Broluzumab Biosimilars Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Broluzumab Biosimilars Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Broluzumab Biosimilars Sales Forecast by Application (2023-2028) & (K Units)

Table 90. Global Broluzumab Biosimilars Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Broluzumab Biosimilars Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Broluzumab Biosimilars Revenue Market Share Forecast by Application (2023-2028)

Table 93. Novartis Basic Information, Broluzumab Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 94. Novartis Broluzumab Biosimilars Product Offered

Table 95. Novartis Broluzumab Biosimilars Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 96. Novartis Main Business

Table 97. Novartis Latest Developments

Table 98. Genentech Basic Information, Broluzumab Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 99. Genentech Broluzumab Biosimilars Product Offered

Table 100. Genentech Broluzumab Biosimilars Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 101. Genentech Main Business

Table 102. Genentech Latest Developments

Table 103. Roche Basic Information, Broluzumab Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 104. Roche Broluzumab Biosimilars Product Offered

Table 105. Roche Broluzumab Biosimilars Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 106. Roche Main Business

Table 107. Roche Latest Developments

Table 108. Pfizer Basic Information, Broluzumab Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 109. Pfizer Broluzumab Biosimilars Product Offered

Table 110. Pfizer Broluzumab Biosimilars Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 111. Pfizer Main Business

Table 112. Pfizer Latest Developments

Table 113. Sartorius Basic Information, Broluzumab Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 114. Sartorius Broluzumab Biosimilars Product Offered

Table 115. Sartorius Broluzumab Biosimilars Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 116. Sartorius Main Business

Table 117. Sartorius Latest Developments

Table 118. Eli Lilly Basic Information, Broluzumab Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 119. Eli Lilly Broluzumab Biosimilars Product Offered

Table 120. Eli Lilly Broluzumab Biosimilars Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 121. Eli Lilly Main Business

Table 122. Eli Lilly Latest Developments

Table 123. Bayer Basic Information, Broluzumab Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 124. Bayer Broluzumab Biosimilars Product Offered

Table 125. Bayer Broluzumab Biosimilars Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 126. Bayer Main Business

Table 127. Bayer Latest Developments

Table 128. Amgen Basic Information, Broluzumab Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 129. Amgen Broluzumab Biosimilars Product Offered

Table 130. Amgen Broluzumab Biosimilars Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 131. Amgen Main Business

Table 132. Amgen Latest Developments

Table 133. PlantForm Basic Information, Broluzumab Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 134. PlantForm Broluzumab Biosimilars Product Offered

Table 135. PlantForm Broluzumab Biosimilars Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 136. PlantForm Main Business

Table 137. PlantForm Latest Developments

Table 138. PharmaPraxis Basic Information, Broluzumab Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 139. PharmaPraxis Broluzumab Biosimilars Product Offered

Table 140. PharmaPraxis Broluzumab Biosimilars Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 141. PharmaPraxis Main Business

Table 142. PharmaPraxis Latest Developments

Table 143. Samsung Bioepis Basic Information, Broluzumab Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 144. Samsung Bioepis Broluzumab Biosimilars Product Offered

Table 145. Samsung Bioepis Broluzumab Biosimilars Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 146. Samsung Bioepis Main Business

Table 147. Samsung Bioepis Latest Developments

Table 148. Centus Basic Information, Broluzumab Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 149. Centus Broluzumab Biosimilars Product Offered

Table 150. Centus Broluzumab Biosimilars Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 151. Centus Main Business

Table 152. Centus Latest Developments

Table 153. Cadila Pharmaceuticals Basic Information, Broluzumab Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 154. Cadila Pharmaceuticals Broluzumab Biosimilars Product Offered

Table 155. Cadila Pharmaceuticals Broluzumab Biosimilars Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 156. Cadila Pharmaceuticals Main Business

Table 157. Cadila Pharmaceuticals Latest Developments

Table 158. Dr Reddy's Basic Information, Broluzumab Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 159. Dr Reddy's Broluzumab Biosimilars Product Offered

Table 160. Dr Reddy's Broluzumab Biosimilars Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 161. Dr Reddy's Main Business

Table 162. Dr Reddy's Latest Developments

Table 163. Aurobindo Pharma Basic Information, Broluzumab Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 164. Aurobindo Pharma Broluzumab Biosimilars Product Offered

Table 165. Aurobindo Pharma Broluzumab Biosimilars Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 166. Aurobindo Pharma Main Business

Table 167. Aurobindo Pharma Latest Developments

Table 168. Biocad Basic Information, Broluzumab Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 169. Biocad Broluzumab Biosimilars Product Offered

Table 170. Biocad Broluzumab Biosimilars Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 171. Biocad Main Business

Table 172. Biocad Latest Developments

Table 173. MAbxience Basic Information, Broluzumab Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 174. MAbxience Broluzumab Biosimilars Product Offered

Table 175. MAbxience Broluzumab Biosimilars Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 176. MAbxience Main Business

Table 177. MAbxience Latest Developments

Table 178. Hetero Basic Information, Broluzumab Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 179. Hetero Broluzumab Biosimilars Product Offered

Table 180. Hetero Broluzumab Biosimilars Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 181. Hetero Main Business

Table 182. Hetero Latest Developments

Table 183. Biocon Basic Information, Broluzumab Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 184. Biocon Broluzumab Biosimilars Product Offered

Table 185. Biocon Broluzumab Biosimilars Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 186. Biocon Main Business

Table 187. Biocon Latest Developments

Table 188. Kirin Biologics Basic Information, Broluzumab Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 189. Kirin Biologics Broluzumab Biosimilars Product Offered

Table 190. Kirin Biologics Broluzumab Biosimilars Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 191. Kirin Biologics Main Business

Table 192. Kirin Biologics Latest Developments

Table 193. Mylan Basic Information, Broluzumab Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 194. Mylan Broluzumab Biosimilars Product Offered

Table 195. Mylan Broluzumab Biosimilars Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 196. Mylan Main Business

Table 197. Mylan Latest Developments

Table 198. BeiGene Basic Information, Broluzumab Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 199. BeiGene Broluzumab Biosimilars Product Offered

Table 200. BeiGene Broluzumab Biosimilars Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 201. BeiGene Main Business

Table 202. BeiGene Latest Developments

Table 203. Innovent Basic Information, Broluzumab Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 204. Innovent Broluzumab Biosimilars Product Offered

Table 205. Innovent Broluzumab Biosimilars Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 206. Innovent Main Business

Table 207. Innovent Latest Developments

Table 208. Qilu Pharmaceutical Basic Information, Broluzumab Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 209. Qilu Pharmaceutical Broluzumab Biosimilars Product Offered

Table 210. Qilu Pharmaceutical Broluzumab Biosimilars Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 211. Qilu Pharmaceutical Main Business

Table 212. Qilu Pharmaceutical Latest Developments

Table 213. Hengrui Pharmaceuticals Basic Information, Broluzumab Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 214. Hengrui Pharmaceuticals Broluzumab Biosimilars Product Offered

Table 215. Hengrui Pharmaceuticals Broluzumab Biosimilars Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 216. Hengrui Pharmaceuticals Main Business

Table 217. Hengrui Pharmaceuticals Latest Developments

Table 218. Hisun Pharmaceutical Basic Information, Broluzumab Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 219. Hisun Pharmaceutical Broluzumab Biosimilars Product Offered

Table 220. Hisun Pharmaceutical Broluzumab Biosimilars Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 221. Hisun Pharmaceutical Main Business

Table 222. Hisun Pharmaceutical Latest Developments

Table 223. TOT BIOPHARM Basic Information, Broluzumab Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 224. TOT BIOPHARM Broluzumab Biosimilars Product Offered

Table 225. TOT BIOPHARM Broluzumab Biosimilars Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 226. TOT BIOPHARM Main Business

Table 227. TOT BIOPHARM Latest Developments

Table 228. Luye Pharmaceutical Basic Information, Broluzumab Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 229. Luye Pharmaceutical Broluzumab Biosimilars Product Offered

Table 230. Luye Pharmaceutical Broluzumab Biosimilars Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 231. Luye Pharmaceutical Main Business

Table 232. Luye Pharmaceutical Latest Developments

Table 233. Henlius Basic Information, Broluzumab Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 234. Henlius Broluzumab Biosimilars Product Offered

Table 235. Henlius Broluzumab Biosimilars Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 236. Henlius Main Business

Table 237. Henlius Latest Developments

List of Figures

Figure 1. Picture of Broluzumab Biosimilars

Figure 2. Broluzumab Biosimilars Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Broluzumab Biosimilars Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Broluzumab Biosimilars Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Broluzumab Biosimilars Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Beovu

Figure 10. Product Picture of Vsiqq

Figure 11. Product Picture of Others

Figure 12. Global Broluzumab Biosimilars Sales Market Share by Type in 2021

Figure 13. Global Broluzumab Biosimilars Revenue Market Share by Type (2017-2022)

Figure 14. Broluzumab Biosimilars Consumed in ARMD

Figure 15. Global Broluzumab Biosimilars Market: ARMD (2017-2022) & (K Units)

Figure 16. Broluzumab Biosimilars Consumed in Kaposi Sarcoma

Figure 17. Global Broluzumab Biosimilars Market: Kaposi Sarcoma (2017-2022) & (K Units)

Figure 18. Broluzumab Biosimilars Consumed in Glioblastoma

Figure 19. Global Broluzumab Biosimilars Market: Glioblastoma (2017-2022) & (K Units)

Figure 20. Global Broluzumab Biosimilars Sales Market Share by Application (2017-2022)

Figure 21. Global Broluzumab Biosimilars Revenue Market Share by Application in 2021

Figure 22. Broluzumab Biosimilars Revenue Market by Company in 2021 ($ Million)

Figure 23. Global Broluzumab Biosimilars Revenue Market Share by Company in 2021

Figure 24. Global Broluzumab Biosimilars Sales Market Share by Geographic Region (2017-2022)

Figure 25. Global Broluzumab Biosimilars Revenue Market Share by Geographic Region in 2021

Figure 26. Global Broluzumab Biosimilars Sales Market Share by Region (2017-2022)

Figure 27. Global Broluzumab Biosimilars Revenue Market Share by Country/Region in 2021

Figure 28. Americas Broluzumab Biosimilars Sales 2017-2022 (K Units)

Figure 29. Americas Broluzumab Biosimilars Revenue 2017-2022 ($ Millions)

Figure 30. APAC Broluzumab Biosimilars Sales 2017-2022 (K Units)

Figure 31. APAC Broluzumab Biosimilars Revenue 2017-2022 ($ Millions)

Figure 32. Europe Broluzumab Biosimilars Sales 2017-2022 (K Units)

Figure 33. Europe Broluzumab Biosimilars Revenue 2017-2022 ($ Millions)

Figure 34. Middle East & Africa Broluzumab Biosimilars Sales 2017-2022 (K Units)

Figure 35. Middle East & Africa Broluzumab Biosimilars Revenue 2017-2022 ($ Millions)

Figure 36. Americas Broluzumab Biosimilars Sales Market Share by Country in 2021

Figure 37. Americas Broluzumab Biosimilars Revenue Market Share by Country in 2021

Figure 38. United States Broluzumab Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 39. Canada Broluzumab Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 40. Mexico Broluzumab Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 41. Brazil Broluzumab Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 42. APAC Broluzumab Biosimilars Sales Market Share by Region in 2021

Figure 43. APAC Broluzumab Biosimilars Revenue Market Share by Regions in 2021

Figure 44. China Broluzumab Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 45. Japan Broluzumab Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 46. South Korea Broluzumab Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 47. Southeast Asia Broluzumab Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 48. India Broluzumab Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 49. Australia Broluzumab Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 50. Europe Broluzumab Biosimilars Sales Market Share by Country in 2021

Figure 51. Europe Broluzumab Biosimilars Revenue Market Share by Country in 2021

Figure 52. Germany Broluzumab Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 53. France Broluzumab Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 54. UK Broluzumab Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 55. Italy Broluzumab Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 56. Russia Broluzumab Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 57. Middle East & Africa Broluzumab Biosimilars Sales Market Share by Country in 2021

Figure 58. Middle East & Africa Broluzumab Biosimilars Revenue Market Share by Country in 2021

Figure 59. Egypt Broluzumab Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 60. South Africa Broluzumab Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 61. Israel Broluzumab Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 62. Turkey Broluzumab Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 63. GCC Country Broluzumab Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 64. Manufacturing Cost Structure Analysis of Broluzumab Biosimilars in 2021

Figure 65. Manufacturing Process Analysis of Broluzumab Biosimilars

Figure 66. Industry Chain Structure of Broluzumab Biosimilars

Figure 67. Channels of Distribution

Figure 68. Distributors Profiles